Synthetic peptide corresponding to a region within internal sequence amino acids 360-409 (MEIAVVAGFA AFLGKYLEQQ FNLTTSSANQ LLGMTAIPCA CLGIFLGGLL) of Human SLCO3A1.
Conjugate
Unconjugated
Applications
Application Notes
WB: 1μg/ml
Target
Alternative Names
SLCO3A1; solute carrier organic anion transporter family, member 3A1; SLC21A11, solute carrier family 21 (organic anion transporter), member 11; solute carrier organic anion transporter family member 3A1; OATP D; OATP3A1; FLJ40478; OATP D; OATP RP3; OATP3A1; OATPD; OATPRP3; Organic anion transporter polypeptide related protein 3; Organic anion transporting polypeptide D; PGE1 transporter; SLC21A11; Sodium independent organic anion transporter D; Solute carrier family 21 (organic anion transporter) member 11; Solute carrier family 21 member 11; Solute carrier organic anion transporter family member 3A1; OATPRP3; OATP-RP3; PGE1 transporter; solute carrier family 21 member 11; organic anion-transporting polypeptide D; sodium-independent organic anion transporter D; organic anion transporter polypeptide-related protein 3; solute carrier family 21 (organic anion transporter), member 11; OATPD; OATP-D; SLC21A11;
SLC-mediated transmembrane transport, organism-specific biosystem; Transmembrane transport of small molecules, organism-specific biosystem; Transport of organic anions, organism-specific biosystem; Transport of vitamins, nucleosides, and related molecules, organism-specific biosystem;
Citations
Publication ()
Have you cited CABT-BL5712 in a publication? Let us know and earn a reward for your research.
My Review for Anti-SLCO3A1 (aa 360-409) polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.